1. Home
  2. BMRN vs IT Comparison

BMRN vs IT Comparison

Compare BMRN & IT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$55.48

Market Cap

10.5B

Sector

Health Care

ML Signal

HOLD

Logo Gartner Inc.

IT

Gartner Inc.

HOLD

Current Price

$148.88

Market Cap

11.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMRN
IT
Founded
1996
1979
Country
United States
United States
Employees
3221
40
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.5B
11.0B
IPO Year
1999
2010

Fundamental Metrics

Financial Performance
Metric
BMRN
IT
Price
$55.48
$148.88
Analyst Decision
Buy
Hold
Analyst Count
18
9
Target Price
$88.22
$216.63
AVG Volume (30 Days)
1.7M
1.3M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.80
9.65
Revenue
$1,313,646,000.00
$2,021,441,000.00
Revenue This Year
$15.02
$3.64
Revenue Next Year
$12.23
$5.12
P/E Ratio
$30.52
$16.00
Revenue Growth
17.62
13.30
52 Week Low
$50.76
$139.18
52 Week High
$66.28
$451.73

Technical Indicators

Market Signals
Indicator
BMRN
IT
Relative Strength Index (RSI) 45.29 42.65
Support Level $51.77 $142.32
Resistance Level $56.21 $163.50
Average True Range (ATR) 1.36 7.14
MACD 0.08 0.01
Stochastic Oscillator 41.16 34.30

Price Performance

Historical Comparison
BMRN
IT

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About IT Gartner Inc.

Gartner Inc delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. It delivers its products and services globally through three reportable segments - Business and Technology Insights, Conferences and Consulting. Insights equips executives and their teams from every Majority function, geography, industry and sector with actionable, objective insights, guidance and tools. Conferences provides executives and teams across an organization the opportunity to learn, share and network. and Consulting serves senior executives technology-driven strategic initiatives leveraging the power of Gartner's actionable, objective insight. The Majority revenue is derived from the Insights segment.

Share on Social Networks: